UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 10 | October 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 11
November-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2311298


Registration ID:
528043

Page Number

c722-c730

Share This Article


Jetir RMS

Title

Tirzepatide:- To Improve Blood Sugar Control in Diabetes In Addition Of To Diet And Exercise

Abstract

ABSTRACT:- The prevalence of Type-2 diabetes is an increasing global problem. Especially in developed countries and is reered as twin epidemics. Such as, Advanced treatment aprroches are needed.Tirzepatide developed by eli lily was under the brand name 'mounsaro' by the united states Food Drug administration (FDA)in may 2022. Tirzepatide, sold under the brand name mounjaro is medication. Used for the treatment of type-2 diabetes. Tirzepatide is given by the weakly subcutaneous injection (under the skin). Common side effects may include like (Nausea, vomiting ,diarrhea,Constipation, abdominal) discomfort and abdominal pain. The type -2 diabetes drug tirzepatide has been reported to induced weight loss in patients with diabetes.

Key Words

KEYWORD:- tirzepatide, twincretin, short peptide, incretins, diabetes, obesity

Cite This Article

"Tirzepatide:- To Improve Blood Sugar Control in Diabetes In Addition Of To Diet And Exercise", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 11, page no.c722-c730, November-2023, Available :http://www.jetir.org/papers/JETIR2311298.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Tirzepatide:- To Improve Blood Sugar Control in Diabetes In Addition Of To Diet And Exercise", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 11, page no. ppc722-c730, November-2023, Available at : http://www.jetir.org/papers/JETIR2311298.pdf

Publication Details

Published Paper ID: JETIR2311298
Registration ID: 528043
Published In: Volume 10 | Issue 11 | Year November-2023
DOI (Digital Object Identifier):
Page No: c722-c730
Country: Buldana, Maharashtra , India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000172

Print This Page

Current Call For Paper

Jetir RMS